This Viewpoint promotes surrogate decision-making based on patient process preferences that allows surrogate decision-makers and clinicians to make decisions in a manner that is adaptable to evolving cancer therapies and respects the values of patients.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Liquid Biopsies for Cancer | 0 | 8.31 | 10-08-2026 |
| 2 | Management of Soft Tissue and Visceral Leiomyosarcomas | 0 | 7.48 | 10-09-2026 |
| 3 | Uncertainty and Ethical Permissibility in Youth Gender Care | 0 | 9.9 | 03-08-2026 |
| 4 | Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer | 0 | 7.64 | 01-10-2024 |
| 5 | Минздрав утвердил новый порядок оказания помощи пациентам с онкозаболеваниями | 0 | 0 | 02-04-2021 |
| 6 | Hybrid model may expand access to integrative oncology | 0 | 14.62 | 22-07-2026 |
| 7 | The profound impact of cancer pain on patients’ lives | 5 | 7 | 06-07-2026 |
| 8 | No Difference in DFS Between Post-adjuvant Chemotherapy and Placebo In High-Risk Patients Identified Through ctDNA-based MRD Assessment After CRC Resection | 0 | 5 | 22-06-2026 |
| 9 | AI digital twin platform advances personalized cancer treatment planning | 0 | 10.93 | 13-08-2026 |